GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRxneffy is the first and only needle-free treatment for Type I allergic reactions, including anaphylaxis for adults and children who weigh =30 kg (66 lbs.) SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS Pharmaceuticals, Inc. (“ARS Pharmaceuticals”) to offer the lowest discounted cash price for neffy® in retail pharmacy locations. Available for purchase in-store this week, consumers who have been prescribed neffy can now access a pack of two single-use neffy devices for $199 at more than 70,000 pharmacies nationwide exclusively through GoodRx.Approved by the Food and Drug Administration in August, neffy is the first needle-free treatment for Type I allergic reactions, including anaphylaxis, offering an innovative alternative to auto-injectors. U
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- NCPDP Foundation Awards $149,123 Grant to NYU Grossman School of Medicine to Study the Impact of Real-Time Prescription Benefit RecommendationsPR Web
- Economists back legislative effort to reveal hidden health care prices [USA TODAY]USA TODAY
- NCPDP Foundation Awards $75,000 to D.A.W. Systems to Help Bring ePrescribing to Veterinary Practices and Pharmacies [Yahoo! Finance]Yahoo! Finance
- 'A great step forward': Nearly 9 million Americans to benefit from Medicare drug price cuts [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 8/8/24 - Beat
GDRX
Sec Filings
- 9/9/24 - Form 4
- 9/9/24 - Form 4
- 9/9/24 - Form 4
- GDRX's page on the SEC website